GI is the most common specialty in terms of case volume and the sixth most popular specialty with management companies, according to data from VMG Health and HealthCare Appraisers. Here are 32 notable ...
- On track to submit a 510(k) to the U.S. FDA for the Pure-Vu Gen 4 Gastro device in Q4 2023 to support the 400,000 upper GI bleeds and other procedures with impaired visualization in the U.S.- - Pure ...
From AI-assisted endoscopy and triage models to outpatient expansion, these are the disruptors gastroenterologists told Becker’s will define the specialty’s next chapter. Question: What do you see as ...
The upper GI procedure was performed by Dr. Brian Hanson, gastroenterologist and Assistant Professor, Medicine, at the University of Minnesota Pure-Vu EVS Gastro addresses the Upper GI market, an area ...
Gastroenterologists concerned over the management of anticoagulant and antiplatelet drugs during gastrointestinal (GI) procedures now have new guidance in the first set of recommendations to be ...
A recent study found that the use and cost of anesthesia services in gastroenterology procedures is increasing, according to a Gastroenterology & Endoscopy News report. The study, published in the ...
Provider groups shared varied reactions to changes that insurance giant UnitedHealthcare is making to its policies for coverage of various gastroenterology procedures, including colonoscopies. In ...
HealthDay News — The risks of cardiopulmonary adverse events are similar for propofol sedation versus traditional agents in gastrointestinal endoscopic procedures, with fewer complications associated ...
Please provide your email address to receive an email when new articles are posted on . The European Commission has given a CE mark to Seal-G, a surgical sealant designed to reduce leaks after ...
This article is brought to you by Children's Hospital New Orleans. Earlier this year, Xinovia’s mom became increasingly concerned when her healthy two-year-old began suffering from stomach pain, ...
FORT LAUDERDALE, Fla., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results